期刊文献+

甲状旁腺高血压因子与原发性高血压的关系 被引量:2

THE RELATIONSHIP BETWEEN PARATHYROID HYPERTENSIVE FACTOR AND ES-SENTIAL HYPERTENSION
原文传递
导出
摘要 探讨153例原发性高血压患者血浆中甲状旁腺高血压因子(PHF)对正常大鼠的升压作用,并测定了血浆中的甲状旁腺素(PTH)水平.结果表明61例血浆PHF可使正常大鼠的血压产生延迟性升高,在注射后10分钟开始有反应,50分钟达高峰,70分钟恢复到注射前血压水平;另92例血浆未能产生升压效应.153例血浆PTH水平远高于正常对照组,有PHF组和无PHF组间无明显差异,但与正常组比较差异均有显著性,提示升高血压不依赖于PTH,而是通过PHF起作用. The effect of plasma parathyroid hypertensive factor (PHF)from 153 essential hypertensive subjects on pressor response in normotensive rats was evaluated and plasma levels of parathyroid hormone (PTH) in these patients were measured. The results showed that PHF from 61 patients could induce a delayed increase in blood pressure in the normotensive rats. Mean arterial pressure (MAP) began to increase at 10 minutes after injection and a peak response was reached at 50 minutes while pre-injection MAP level was recovered at 70 minutes. On the other hand, plasma PHF in remaining 92 patients failed to induce a pressor effect. Plasma PTH in the 153 patients were considerably higher than those of the control, and the plasma PTH from the two groups, either with or without PHF, showed significant difference in comparison with the control, but plasma PTH between these two groups did not show significant difference. The results have suggested that pressor effect was independent of PTH but depends on PHF.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 1996年第3期141-143,共3页 Chinese Journal of Endocrinology and Metabolism
基金 国家自然科学基金资助项目
关键词 甲状旁腺 高血压因子 高血压 Hypertensive factor, parathyroid Hormone, parathyroid
  • 相关文献

参考文献5

  • 1赵睿珊,中国病理生理杂志,1995年,11卷,429页
  • 2赵睿珊,中国应用生理学杂志,1994年,10卷,332页
  • 3Pang P K T,Am J Hypertens,1991年,4卷,472页
  • 4Pang P K T,Am J Hypertens,1989年,2卷,898页
  • 5Pang P K T,J Exp Zool,1984年,232卷,691页

同被引文献30

  • 1袁志敏,饶中和.甲状旁腺素与原发性高血压[J].临床荟萃,1994,9(2):51-53. 被引量:1
  • 2赵睿珊,朱文萍,王素敏,王薇,王辅才,胡晓东.血浆高血压因子的实验研究[J].中国病理生理杂志,1995,11(4):429-432. 被引量:1
  • 3赵睿珊,王辅才,朱文萍,胡晓东.原发性高血压患者血浆中甲状旁腺高血压因子对细胞钙通道的作用[J].高血压杂志,1996,4(3):182-184. 被引量:2
  • 4Banerjee P, Chatterjee M. Antiproliferative role of vitamin D and its analogs--a brief overview. Mol Cell Biochem, 2003,253:247-254.
  • 5Zittermann A, Schleithoff SS, Tenderich G, et al. Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure.'? J Am Coil Cardiol, 2003,41:105-112.
  • 6Lee JI, Oh SJ, Ha WC, et al. Serum 25-hydroxyvitamin D concentration and arterial stiffness among type 2 diabetes. Diab Res Clin Pratt, 2012,95:42-47.
  • 7Cruickshank K, Riste L, Anderson SG, et al. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation, 2002,106:2085-2090.
  • 8Yu JR, Lee SA, Lee JG, et al. Serum vitamin d status and its relationship to metabolic parameters in patients with type 2 diabetes mellitus. Chonnam Med J, 2012,48 : 108-115.
  • 9Chonchol M, Cigolini M, Targher G. Association between 25- hydroxyvitamin D deficiency and cardiovascular disease in type 2 diabetic patients with mild kidney dysfunction. Nephrol Dial Transplant, 2008,23:269-274.
  • 10Mattila C, Knekt P, Manuisto S, et al. Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes. Diabetes Care, 2007,30 : 2569 -2570.

引证文献2

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部